Variant report
Variant | esv2761215 |
---|---|
Chromosome Location | chr8:63212769-63229146 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11986195 | chr8:63212769-63212770 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs535562389 | chr8:63212775-63212776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557130453 | chr8:63212831-63212832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575391919 | chr8:63212881-63212882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555840021 | chr8:63212898-63212899 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539489512 | chr8:63212949-63212950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557727300 | chr8:63213143-63213144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs143348864 | chr8:63213185-63213186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185665918 | chr8:63213188-63213189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190697518 | chr8:63213230-63213231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539354598 | chr8:63213287-63213288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573861279 | chr8:63213308-63213309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368056287 | chr8:63213348-63213349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544385386 | chr8:63213422-63213423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562670270 | chr8:63213427-63213428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs56064221 | chr8:63213439-63213440 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs370664115 | chr8:63213467-63213468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs193018995 | chr8:63213518-63213519 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112216100 | chr8:63213520-63213521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs58402023 | chr8:63213524-63213525 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs528376838 | chr8:63213544-63213545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546842463 | chr8:63213604-63213605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568349897 | chr8:63213677-63213678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575474382 | chr8:63213702-63213703 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184484565 | chr8:63213736-63213737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs72401958 | chr8:63213762-63213763 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs59094236 | chr8:63213764-63213765 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs61472534 | chr8:63213765-63213766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs56723840 | chr8:63213767-63213768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539962503 | chr8:63213770-63213771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550794909 | chr8:63213838-63213839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114689247 | chr8:63213860-63213861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs77264713 | chr8:63213869-63213870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188268953 | chr8:63213872-63213873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143500714 | chr8:63213892-63213893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7845607 | chr8:63213937-63213938 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs115225057 | chr8:63213962-63213963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7829743 | chr8:63214002-63214003 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs573973330 | chr8:63214019-63214020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150967757 | chr8:63214064-63214065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532545927 | chr8:63214068-63214069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs5014328 | chr8:63214076-63214077 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs577723266 | chr8:63214135-63214136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs74511855 | chr8:63214147-63214148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs532241098 | chr8:63214179-63214180 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs377447960 | chr8:63214238-63214239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs140688197 | chr8:63214262-63214263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs564892527 | chr8:63214295-63214296 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371344202 | chr8:63214360-63214361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs145794167 | chr8:63214383-63214384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:63209600-63214000 | Weak transcription | Brain Germinal Matrix | brain |
2 | chr8:63209600-63214400 | Weak transcription | Fetal Brain Female | brain |
3 | chr8:63209600-63214600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
4 | chr8:63212400-63216200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr8:63212600-63213400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr8:63214000-63214600 | Enhancers | Fetal Brain Male | brain |
7 | chr8:63214000-63215000 | Enhancers | Brain Germinal Matrix | brain |
8 | chr8:63214400-63216200 | Enhancers | Fetal Brain Female | brain |
9 | chr8:63214600-63215800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr8:63215000-63216000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr8:63215200-63215800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr8:63215200-63216000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr8:63215200-63216000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr8:63215400-63215800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr8:63215400-63216000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr8:63215600-63216000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
17 | chr8:63216000-63217200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
18 | chr8:63217400-63217600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr8:63219200-63219600 | Enhancers | HSMM | muscle |
20 | chr8:63225200-63225600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
21 | chr8:63225200-63227000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
22 | chr8:63225600-63234400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
23 | chr8:63226800-63227400 | Enhancers | Adipose Nuclei | Adipose |
24 | chr8:63227000-63227600 | Enhancers | Colon Smooth Muscle | Colon |